Can phage effectively treat multidrug-resistant plague?

References

• Butler T. Plague into the 21st century. Clin Infect Dis 2009; 49:736 - 42; http://dx.doi.org/10.1086/604718; PMID: 19606935
   PubMed Web of Science ®Google Scholar
• Galimand M, Courvalin P. Plague treatment and resistance to antimicrobial agents. In: Carniel E and Hinnebusch BJ, eds. Yersinia: Systems Biology and Control. Norfolk: Caister Academic Press 2012; 109-114.
   Google Scholar
• Kiefer D, Dalantai G, Damdindorj T, Riehm JM, Tomaso H, Zöller L, et al. Phenotypical characterization of Mongolian Yersinia pestis strains. Vector Borne Zoonotic Dis 2012; 12:183 - 8; http://dx.doi.org/10.1089/vbz.2011.0748; PMID: 22022819
   PubMed Web of Science ®Google Scholar
• d’Hérelle F. Essai de traitement de la peste bubonique par le bactériophage. Presse Med 1925; 33:1393 - 4
   Google Scholar
• Anisimov AP, Amoako KK. Treatment of plague: promising alternatives to antibiotics. J Med Microbiol 2006; 55:1461 - 75; http://dx.doi.org/10.1099/jmm.0.46697-0; PMID: 17030904
   PubMed Web of Science ®Google Scholar
• Pollitzer R. Plague. Geneva: WHO 1954; 409-482.
   Google Scholar
• Sulakvelidze A, Alavidze Z, Morris JG Jr.. Bacteriophage therapy. Antimicrob Agents Chemother 2001; 45:649 - 59; http://dx.doi.org/10.1128/AAC.45.3.649-659.2001; PMID: 11181338
   PubMed Web of Science ®Google Scholar
• Burrowes B, Harper DR, Anderson J, McConville M, Enright MC. Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens. Expert Rev Anti Infect Ther 2011; 9:775 - 85; http://dx.doi.org/10.1586/eri.11.90; PMID: 21905786
   PubMed Web of Science ®Google Scholar
• Filippov AA, Sergueev KV, He Y, Huang XZ, Gnade BT, Mueller AJ, et al. Bacteriophage-resistant mutants in Yersinia pestis: identification of phage receptors and attenuation for mice. PLoS One 2011; 6:e25486; http://dx.doi.org/10.1371/journal.pone.0025486; PMID: 21980477
   PubMed Web of Science ®Google Scholar
• Filippov AA, Sergueev KV, He Y, Nikolich MP. Bacteriophages capable of lysing Yersinia pestis and Yersinia pseudotuberculosis: efficiency of plating tests and identification of receptors in escherichia coli K-12. Adv Exp Med Biol 2012; 954:123 - 34; http://dx.doi.org/10.1007/978-1-4614-3561-7_16; PMID: 22782755
   PubMed Web of Science ®Google Scholar
• Filippov AA, Sergueev KV, He Y, Huang XZ, Gnade BT, Mueller AJ, et al. Bacteriophage therapy of experimental bubonic plague in mice. Adv Exp Med Biol 2012; 954:337 - 48; http://dx.doi.org/10.1007/978-1-4614-3561-7_41; PMID: 22782780
   PubMed Web of Science ®Google Scholar
• Garcia E, Elliott JM, Ramanculov E, Chain PS, Chu MC, Molineux IJ. The genome sequence of Yersinia pestis bacteriophage phiA1122 reveals an intimate history with the coliphage T3 and T7 genomes. J Bacteriol 2003; 185:5248 - 62; http://dx.doi.org/10.1128/JB.185.17.5248-5262.2003; PMID: 12923098
   PubMed Web of Science ®Google Scholar
• Sergueev KV, He Y, Borschel RH, Nikolich MP, Filippov AA. Rapid and sensitive detection of Yersinia pestis using amplification of plague diagnostic bacteriophages monitored by real-time PCR. PLoS One 2010; 5:e11337; http://dx.doi.org/10.1371/journal.pone.0011337; PMID: 20596528
   PubMedGoogle Scholar
• Kiljunen S, Datta N, Dentovskaya SV, Anisimov AP, Knirel YA, Bengoechea JA, et al. Identification of the lipopolysaccharide core of Yersinia pestis and Yersinia pseudotuberculosis as the receptor for bacteriophage φA1122. J Bacteriol 2011; 193:4963 - 72; http://dx.doi.org/10.1128/JB.00339-11; PMID: 21764935
   PubMed Web of Science ®Google Scholar
• Zhao X, Wu W, Qi Z, Cui Y, Yan Y, Guo Z, et al. The complete genome sequence and proteomics of Yersinia pestis phage Yep-phi. J Gen Virol 2011; 92:216 - 21; http://dx.doi.org/10.1099/vir.0.026328-0; PMID: 20943893
   PubMed Web of Science ®Google Scholar
• Schwudke D, Ergin A, Michael K, Volkmar S, Appel B, Knabner D, et al. Broad-host-range Yersinia phage PY100: genome sequence, proteome analysis of virions, and DNA packaging strategy. J Bacteriol 2008; 190:332 - 42; http://dx.doi.org/10.1128/JB.01402-07; PMID: 17965162
   PubMed Web of Science ®Google Scholar
• Garcia E, Chain P, Elliott JM, Bobrov AG, Motin VL, Kirillina O, et al. Molecular characterization of L-413C, a P2-related plague diagnostic bacteriophage. Virology 2008; 372:85 - 96; http://dx.doi.org/10.1016/j.virol.2007.10.032; PMID: 18045639
   PubMed Web of Science ®Google Scholar
• Levin BR, Bull JJ. Population and evolutionary dynamics of phage therapy. Nat Rev Microbiol 2004; 2:166 - 73; http://dx.doi.org/10.1038/nrmicro822; PMID: 15040264
   PubMed Web of Science ®Google Scholar
• Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor: Cold Spring Harbor Laboratory Press 1989.
   Google Scholar
• Cerveny KE, DePaola A, Duckworth DH, Gulig PA. Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice. Infect Immun 2002; 70:6251 - 62; http://dx.doi.org/10.1128/IAI.70.11.6251-6262.2002; PMID: 12379704
   PubMed Web of Science ®Google Scholar
• Lukaszewski RA, Kenny DJ, Taylor R, Rees DG, Hartley MG, Oyston PCF. Pathogenesis of Yersinia pestis infection in BALB/c mice: effects on host macrophages and neutrophils. Infect Immun 2005; 73:7142 - 50; http://dx.doi.org/10.1128/IAI.73.11.7142-7150.2005; PMID: 16239508
   PubMed Web of Science ®Google Scholar
• Capparelli R, Parlato M, Borriello G, Salvatore P, Iannelli D. Experimental phage therapy against Staphylococcus aureus in mice. Antimicrob Agents Chemother 2007; 51:2765 - 73; http://dx.doi.org/10.1128/AAC.01513-06; PMID: 17517843
   PubMed Web of Science ®Google Scholar
• Heo YJ, Lee YR, Jung HH, Lee J, Ko G, Cho YH. Antibacterial efficacy of phages against Pseudomonas aeruginosa infections in mice and Drosophila melanogaster.. Antimicrob Agents Chemother 2009; 53:2469 - 74; http://dx.doi.org/10.1128/AAC.01646-08; PMID: 19364866
   PubMed Web of Science ®Google Scholar
• McVay CS, Velásquez M, Fralick JA. Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model. Antimicrob Agents Chemother 2007; 51:1934 - 8; http://dx.doi.org/10.1128/AAC.01028-06; PMID: 17387151
   PubMed Web of Science ®Google Scholar
• Byrne WR, Welkos SL, Pitt ML, Davis KJ, Brueckner RP, Ezzell JW, et al. Antibiotic treatment of experimental pneumonic plague in mice. Antimicrob Agents Chemother 1998; 42:675 - 81; PMID: 9517950
   PubMed Web of Science ®Google Scholar
• Steward J, Lever MS, Russell P, Beedham RJ, Stagg AJ, Taylor RR, et al. Efficacy of the latest fluoroquinolones against experimental Yersinia pestis.. Int J Antimicrob Agents 2004; 24:609 - 12; http://dx.doi.org/10.1016/j.ijantimicag.2004.06.011; PMID: 15555886
   PubMed Web of Science ®Google Scholar
• Merril CR, Biswas B, Carlton R, Jensen NC, Creed GJ, Zullo S, et al. Long-circulating bacteriophage as antibacterial agents. Proc Natl Acad Sci U S A 1996; 93:3188 - 92; http://dx.doi.org/10.1073/pnas.93.8.3188; PMID: 8622911
   PubMed Web of Science ®Google Scholar